同方友友(01868.HK):暫停同方證券的第1類受規管活動業務
格隆匯12月7日丨同方友友(01868.HK)宣佈,於2021年12月7日,董事會決定暫停公司全資附屬公司同方證券有限公司("同方證券")根據證券及期貨條例進行的第1類受規管活動業務。同方證券將自2021年12月8日起停止接受新客户,並將逐步終止與現有客户在第1類受規管活動業務方面的關係。
截至2018年、2019年及2020年12月31日止三個年度,公司的證券分部分別錄得虧損人民幣1912.6萬元、人民幣992.3萬元及人民幣2372.8萬元。通過暫停同方證券的第1類受規管活動業務,預計集團將能夠大幅降低勞工成本。董事會認為,暫停同方證券的第1類受規管活動業務符合公司及其股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.